Mr. Meyer is a Co-founder and Managing Member at Life Science Strategy Group, LLC who has managed strategic consulting engagements with biopharmaceutical services (CROs/BPOs/CDMOs) across all phases of preclinical and clinical development and commercial services. He has also consulted extensively to pharmaceutical, drug delivery, specialty pharma and biotechnology clients in areas including dermatology, autoimmune disease, oncology, diabetes, pain management, and infectious disease, among others. He has served as the day-to-day project lead on numerous strategic engagements including brand equity studies, opportunity assessments, competitive intelligence, pricing and reimbursement analyses, forecasting, competitive benchmarking, positioning and messaging strategy and clinical trial design analysis. He has also provided product licensing support to clients, including candidate identification, analysis, forecasting, valuation and portfolio analysis. Mr. Meyer was a Director in the Life Sciences group at Navigant Consulting, Inc.. Mr. Meyer was also a Research Associate in the department of inflammatory disease at Roche Bioscience for 6 years and holds master's degrees in biomedical science and business administration.Specialties: Contract Research Organizations (CRO), Drug Delivery, Specialty Pharmaceuticals, Biotechnology, Pharmaceuticals, Strategic Planning, Product Commercialization, Product Planning, Licensing, Market Research, Life Sciences, Marketing Strategy